|
|
| MRD / Regn No. |
: 20260000315 |
Date |
: 29/06/2026 |
| Patient Name |
: Punam Saha |
Age & Gender |
: 36 Yrs. / Female |
| Contact No. |
: 9831731751 |
UHID |
: |
| Ht / Wt / BMI |
: 161 / 78 / 30.09 |
BP S / BP D |
: / |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (15/Apr/2026) | OBESITY (15/Apr/2026) | OBESITY WITH METABOLIC COMPLICATIONS (15/Apr/2026) | VITAMIN D DEFICIENCY (15/Apr/2026) | |
|
Subjective |
: |
HX OF GDM,POST GDM RECURRENCE OF DM,DYSESTHESIAS,HAS STOPPED MEDICATIONS
|
|
Objective |
: |
NONE |
|
Analysis |
: |
OBESITY,TYPE 2 DM,VITAMIN D DEFICIENCY |
|
Plan |
: |
RESTART MOUNJARO,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.9 % | HEMOGLOBIN: 11.7 g/dL | MCH: 23.8 pg | MCHC: 29.0 gm % | MCV: 82.3 fl | PCV: 40.4 % | PLATELETS: 153 thou cells/ ul | RBC COUNT: 4.91 million/ul | TOTAL COUNT WBC: 8120 Cells/cmm | FASTING PLASMA GLUCOSE (FPG): 169.76 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 320.25 mg/dL | A\G RATIO: 2 g/dl | ALBUMIN (SERUM): 4.59 g/dL | ALKALINE PHOSPHOTASE: 62.64 IU/L | DIRECT BILIRUBIN: 0.12 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 27.61 U/L | GLOBULIN: 3.00 g/dl | INDIRECT BILIRUBIN: 0.32 | SGOT (AST): 24 U/L | SGPT (ALT): 22 IU/L | TOTAL BILIRUBIN: 0.44 mg/dL | TOTAL PROTEIN: 7.59 g/dl | CREATININE: 0.72 mg/dL | BUN BLOOD UREA NITROGEN: 10.90 mg/dL | URIC ACID: 6.92 | CALCIUM: 9.30 mg/DL | ESR: 12 mm/hour | VITAMIN D (25 OH): 56 ng/mL | POTASSIUM: 4.30 meQ/L | SODIUM: 139 meq/L | HDL HIGH DENSITY LIPOPROTEIN: 36 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 126 mg/dL | TGL TRIGLYCERIDE: 293 mg/dL | TOTAL CHO/HDL RATIO: 6.06 | TOTAL CHOLESTEROL: 221 mg/dl | VLDL: 58 mg/dl | FREE T3: 2.45 ng/dL | FREE T4 : 1.21 ng/dL | TSH : 1.99 mIU/L | FIB4: 1.20 | EGFR EGLOMERULAR FILTRATION RATE: 98.07 mL/min/1.73m2 | FIB4: 1.20 | FIB4: 1.20 | EGFR EGLOMERULAR FILTRATION RATE: 98.07 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 98.07 mL/min/1.73m2 | FREE T3: 2.45 ng/dL | FREE T4 : 1.21 ng/dL | TSH : 1.99 mIU/L |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION TIRZEPATIDE 2.5 MG
MOUNJARO
Medicine For DIABETES OBESITY |
SQ |
ONCE A WEEK |
AS DIRECTED
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA AND VISUAL DISTURBANCES | |
|
2 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: RARE VERY RARE INSTANCES OF EYE DISTURBANCE WITH TIRZEPATIDE HAVE BEEN REPORTED |
| Next Visit |
: 29/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |